Malignant endometrial polyps in postmenopausal breast cancer tamoxifen- treated patients

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 136-141

  Cohen, Ilan ^a   Bernheim, Joel ^a,b   Azaria, Ron ^a   Tepper, Ron ^a   Sharony, Reuven ^a   Beyth, Yoram ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Endometrial polyps; Malignant changes; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; POLYP; POSTMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032833582     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5558     Document Type: Article

References (28)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet. 339:1992;1-15.
2. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E. Tamoxifen and the uterus and endometrium. Lancet. 2:1989;375.
3. De Muylder X, Neven P, De Somer M. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Pathol. 36:1991;127-129.
4. Cohen I, Rosen D JD, Shapira J, Cordoba M, Gilboa S, Altaras M M, Yigael D, Beyth Y. Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynecol. 100:1993;567-570.
5. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen P J, Laatikinen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol. 81:1993;660-664.
6. Cohen I, Rosen D JD, Shapira J, Cordoba M, Gilboa S, Altaras M M, Yigael D, Beyth Y. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and non-treated asymptomatic breast cancer patients. Gynecol Oncol. 5:1994;185-190.
7. Cohen I, Tepper R, Rosen D JD, Shapira J, Cordoba M, Altaras M M, Dror Y, Beth Y. Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol. 55:1994;138-143.
8. Ismail S M. Pathology of endometrium treated with tamoxifen. J Clin Pathol. 47:1994;827-833.
9. Kedar R P, Bourne T H, Powels T J, Collins W P, Ashley S E, Cosgrove D O, Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet. 343:1994;1318-1321.
10. Cohen I, Altaras M M, Shapira J, Tepper R, Rosen D JD, Cordoba M, Beyth Y. Time-dependent effect of tamoxifen therapy on endometrial pathologies in asymptomatic, postmenopausal breast cancer patients. Int J Gynecol Pathol. 15:1996;152-157.
11. Corley D, Rowe J, Curtis M J, Hogan W M, Nuomoff J J, Livolsi V A. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstetrics. 79:1992;111-116.
12. Gibson L E, Barakat R R, Venkarraman E S. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers. Cancer J. 2:1996;35-38.
13. Hann L E, Geiss C S, Bach A M, Tao Y, Baum H J, Barakat R R. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. Am J Radiol. 168:1997;657-661.
14. Tepper R, Beyth Y, Altaras M M, Zalel Y, Shapira J, Cordoba M, Cohen I. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol. 64:1997;386-391.
15. Cohen I, Perel E, Tepper R, Flex D, Figer A, Shapira J, Altaras M M, Fishman Bernheim J, Cordoba M, Yigel D, Beyth Y. Dose-dependent effect of tamoxifen on endometrial pathologies in postmenopausal breast cancer patients. Breast Cancer Res Treat. 1284:1998;1-8.
16. Berliere M, Charles A, Galant C, Donnez J. Uterine side effects of tamox: a need for systemic pretreatment sc. Obstet Gynecol. 91:1998;40-44.
17. Schlesinger C, Kamoi S, Ascher S, Kendell M, Lage J M, Silverberg S G. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol. 17:1998;302-311.
18. Ramondetta, L, M, Sherwood, J, B, Dunton, J, D, Palazzo, J, P, Endometrial cancer in polyps associated with tamoxifen use, Am J Obstet Gynecol, 180: 340, - 341.
19. Cohen I, Perel E, Flex D, Tepper R, Altars M M, Cordoba M, Beyth Y. Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynecologically symptomatic and asymptomatic breast cancer patients. J Clin Pathol. 52:1999;278-282.
20. Fornander T, Cedermak B, Mattson A, Skoog L, Theve T, Askergen J, Rutquist L E, Glas Y, Silfversward C M, Somel A, Wilkins N, Hjalmar M L. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 21:1989;117-120.
21. Fisher B, Costantino J P, Redmond C K, Fisher E B, Wickerham, Cronin W M. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breaand Bowel Project (NSABP)B-14. J Natl Cancer Inst. 86:1994;527-537.
22. van Leeuwen F B, Benraadt J, Coebergh J WW, Kiemeney L A, Gimbrere C H, Otter R. Risk of endometrial cancer after tamoxifen treatment for breast cancer. Lancet. 343:1994;448-452.
23. Barakat R R, Wang G, Curtin J, Vlamis V, Hoskins W J. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol. 55:1994;164-168.
24. Kurman R J, Mazur M T. Benign Diseases of the Endometrium. Kurman R J. Blaustein's Pathology of the Female Genital Tract. 1994;396-397 Springer-Verlag, New York.
25. Salm R. The incidence and significance of early carcinoma in endometrial polyps. J Pathol. 108:1972;47-53.
26. Assikis V J, Neven P, Jordon V C, Vergote I. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer. 32A:1996;1464-1476.
27. Achiron R, Lipitz S, Sivan E, Goldenberg M, Mashiach S. Sonohysterography for ultrasonographic evaluation of tamoxifen associated cystic thickened endometrium. J Ultrasound Med. 14:1995;1-5.
28. Bourne T H, Lawton F, Leather A, Granberg S, Campbell S, Collins W P. Use of intracavitary saline instillation and transvaginal ultrasonography to detect tamoxifen-associated polyps. Ultrasound Obstet Gynecol. 4:1994;73-75.